[Possible dependence of the antifibrillatory action of inderal in experimental myocardial infarct on its effect on oxidation-reduction processes and the blood supply of the heart].
D000818:Animals; D001146:Arrhythmia, Sinus / Q000188:drug therapy*; D003331:Coronary Vessels / Q000187:drug effects*; D004285:Dogs; D006321:Heart / Q000187:drug effects*; D007275:Injections, Intravenous; D008026:Ligation; D009203:Myocardial Infarction / Q000188:drug therapy*; D010085:Oxidative Phosphorylation / Q000187:drug effects*; D011433:Propranolol / Q000494:pharmacology*
D011433:Propranolol
O vozmozhnoĭ zavisimosti antifibrilliatornogo deĭstviia inderala pri éksperimental'nom infarkte miokarda ot ego vliianiia na okislitel'no-vosstanovitel'nye protsessy i krovosnabzhenie serdtsa.